These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 26424683)

  • 1. Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response.
    Bordon JM; Fernandez-Botran R; Wiemken TL; Peyrani P; Uriarte SM; Arnold FW; Rodriquez-Hernandez L; Rane MJ; Kelley RR; Binford LE; Uppatla S; Cavallazzi R; Blasi F; Aliberti S; Restrepo MI; Fazeli S; Mathur A; Rahmani M; Ayesu K; Ramirez J
    Infection; 2015 Dec; 43(6):729-38. PubMed ID: 26424683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study.
    Bordón J; Peyrani P; Brock GN; Blasi F; Rello J; File T; Ramirez J;
    Chest; 2008 Mar; 133(3):618-24. PubMed ID: 18198264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
    Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
    J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of age on the systemic inflammatory response in patients with community-acquired pneumonia.
    van Vught LA; Endeman H; Meijvis SC; Zwinderman AH; Scicluna BP; Biesma DH; van der Poll T
    Clin Microbiol Infect; 2014 Nov; 20(11):1183-8. PubMed ID: 24930498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ability of procalcitonin to predict bacteremia in patients with community acquired pneumonia].
    Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Parejo Miguez R; Flores Chacartegui M; Gallardo Schall P
    Med Clin (Barc); 2014 Apr; 142(7):285-92. PubMed ID: 24120103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
    Jover F; Cuadrado JM; Andreu L; Martínez S; Cañizares R; de la Tabla VO; Martin C; Roig P; Merino J
    Eur J Intern Med; 2008 Jan; 19(1):15-21. PubMed ID: 18206596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and pathogenic significance of bacteremic pneumonia in adult patients with community-acquired pneumococcal pneumonia.
    Kang CI; Song JH; Kim SH; Chung DR; Peck KR; Thamlikitkul V; Wang H; So TM; Hsueh PR; Yasin RM; Carlos CC; Van PH; Perera J
    J Infect; 2013 Jan; 66(1):34-40. PubMed ID: 22922634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of CRB-65 as a prognostic scoring system in adult patients with bacteraemic pneumococcal pneumonia.
    Dwyer R; Hedlund J; Darenberg J; Henriques-Normark B; Naucler P; Runesdotter S; Kalin M
    Scand J Infect Dis; 2011 Jul; 43(6-7):448-55. PubMed ID: 21370939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Krueppel-Like Factor 4 Expression in Phagocytes Regulates Early Inflammatory Response and Disease Severity in Pneumococcal Pneumonia.
    Herta T; Bhattacharyya A; Rosolowski M; Conrad C; Gurtner C; Gruber AD; Ahnert P; Gutbier B; Frey D; Suttorp N; Hippenstiel S; Zahlten J
    Front Immunol; 2021; 12():726135. PubMed ID: 34589087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children.
    Galetto-Lacour A; Alcoba G; Posfay-Barbe KM; Cevey-Macherel M; Gehri M; Ochs MM; Brookes RH; Siegrist CA; Gervaix A
    Pediatr Infect Dis J; 2013 Nov; 32(11):1175-9. PubMed ID: 23694836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical predictors of bacteremia in immunocompetent adult patients hospitalized for community-acquired pneumonia].
    Saldías P F; Reyes B T; Sáez B J; Rain M C; Illanes C P; Briceño V C; Díaz P O
    Rev Med Chil; 2015 May; 143(5):553-61. PubMed ID: 26203565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study.
    Ruiz LA; España PP; Gómez A; Bilbao A; Jaca C; Arámburu A; Capelastegui A; Restrepo MI; Zalacain R
    BMC Geriatr; 2017 Jun; 17(1):130. PubMed ID: 28633626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: clinical and microbiological characteristics in Taiwan, 2001-2008.
    Lin YT; Jeng YY; Chen TL; Fung CP
    BMC Infect Dis; 2010 Oct; 10():307. PubMed ID: 20973971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae.
    Lin SH; Lai CC; Tan CK; Liao WH; Hsueh PR
    Epidemiol Infect; 2011 Sep; 139(9):1307-16. PubMed ID: 20974020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of bacteremia in a cohort of patients with pneumococcal pneumonia.
    Palma I; Mosquera R; Demier C; Vay CA; Famiglietti A; Luna CM
    J Bras Pneumol; 2012; 38(4):422-30. PubMed ID: 22964925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia.
    Cillóniz C; Ceccato A; de la Calle C; Gabarrús A; Garcia-Vidal C; Almela M; Soriano A; Martinez JA; Marco F; Vila J; Torres A
    PLoS One; 2017; 12(8):e0182436. PubMed ID: 28787020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia--over 22 years.
    Jacups SP; Cheng A
    Vaccine; 2011 Jul; 29(33):5386-92. PubMed ID: 21651943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia.
    Brandenburg JA; Marrie TJ; Coley CM; Singer DE; Obrosky DS; Kapoor WN; Fine MJ
    J Gen Intern Med; 2000 Sep; 15(9):638-46. PubMed ID: 11029678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and impact of time to clinical stability in community-acquired pneumococcal pneumonia.
    Takada K; Matsumoto S; Kojima E; Iwata S; Ninomiya K; Tanaka K; Goto D; Shimizu T; Nohara K
    Respir Med; 2014 May; 108(5):806-12. PubMed ID: 24589380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteraemic and non-bacteraemic/urinary antigen-positive pneumococcal community-acquired pneumonia compared.
    van Mens SP; van Deursen AMM; de Greeff SC; de Melker HE; Schouls LM; van der Ende A; Bonten MJM; Sanders EAM; Vlaminckx BJM
    Eur J Clin Microbiol Infect Dis; 2015 Jan; 34(1):115-122. PubMed ID: 25079513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.